The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of the vebreltinib in patients with previously treated, secondary glioblastoma/IDH mutant glioblastoma with PTPRZ1-METFUsion GENe (FUGEN): A randomised, multicentre, open-label, phase II/III trial.
 
Tao Jiang
No Relationships to Disclose
 
Zhaoshi Bao
No Relationships to Disclose
 
Feng-Dong Yang
No Relationships to Disclose
 
Qing Mao
No Relationships to Disclose
 
Shouwei Li
No Relationships to Disclose
 
Yan Qu
No Relationships to Disclose
 
Liang Wang
No Relationships to Disclose
 
Yonggao Mou
No Relationships to Disclose
 
Ru-tong Yu
No Relationships to Disclose
 
Jinsong Wu
No Relationships to Disclose
 
Guangyuan Hu
No Relationships to Disclose
 
Wenbin Li
No Relationships to Disclose
 
Xiaoguang Qiu
No Relationships to Disclose
 
Yun-Qian Li
No Relationships to Disclose
 
Linbo Cai
No Relationships to Disclose